Feline Toxoplasmosis (Toxoplasma gondii): Etiology, Epidemiology, Clinical Signs, Pathology, Diagnostics, Treatment, and Control

Etiology

Feline toxoplasmosis is caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. The parasite exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [1]. The definitive host is the domestic cat and other felids, in which the sexual phase of the life cycle occurs exclusively within the intestinal epithelium [2]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has revealed the transcriptional programs governing merozoite differentiation and gametocyte formation [2]. The pre-sexual stages undergo a specialized cell division process termed endodyogeny, which is characterized by internal budding and is essential for the proliferative expansion required before sexual commitment [1].

The parasite exhibits a clonal population structure with three predominant lineages (Types I, II, and III) that differ in virulence and host range [3]. Genotype distribution studies in animal populations from Bangladesh have demonstrated the circulation of multiple genotypes, with implications for cross-species transmission [3]. The microneme protein MIC17A has been identified as a potential marker for both entero-epithelial and chronic stage infections in cats, reflecting the molecular heterogeneity of parasite stages during feline infection [4].

Epidemiology

Toxoplasma gondii infection is distributed globally, with seroprevalence rates in cats varying widely by geographic region, management practices, and diagnostic methodology [5, 6]. A seroprevalence study in privately-owned and community cats in Hong Kong reported an overall seropositivity of 37.5%, with demographic factors such as age, outdoor access, and raw feeding practices significantly associated with infection risk [5]. In Jordan, the first seroprevalence and molecular detection study of toxoplasmosis in cats found a seropositivity rate of 41.2%, with stray cats and those with outdoor access showing higher odds of infection [6]. PCR detection of T. gondii DNA in fecal samples from stray cats in Bangkok, Thailand, revealed a prevalence of 8.7%, confirming that stray populations serve as important environmental contaminators [7].

The role of wildlife in maintaining T. gondii transmission cycles is substantial. A systematic review and meta-analysis of T. gondii infection in wildlife in China, incorporating machine learning approaches, identified 198 species across 1985-2024 as potential reservoirs, with prevalence patterns influenced by trophic level and habitat type [8]. Migratory and opportunistic wild and domestic birds act as T. gondii carriers, contributing to spatial dissemination of oocysts [9]. Seroprevalence studies in deer populations in Iraq have documented exposure rates of 23.5%, indicating that herbivorous wildlife serve as sentinel species for environmental contamination [10].

Environmental factors are critical determinants of transmission dynamics. Social marginalisation and environmental degradation have been linked to increased T. gondii exposure in urban informal settlements in Brazil, where inadequate sanitation facilitates oocyst accumulation [11]. High seroprevalence rates in dogs from the Pantanal region of Brazil (68.4%) reflect the intense environmental contamination in wetland ecosystems [12]. In livestock, seroprevalence in dairy cattle from Eastern Anatolia, Turkey, reached 32.1%, with grazing management and water source identified as risk factors [13]. Aborted fetal tissues from goats in Algeria have yielded molecular evidence of T. gondii DNA, confirming transplacental transmission as a significant route in small ruminants [14]. Similarly, an aborted equine fetus in Brazil tested positive by PCR, with serological evidence of infection in mares enrolled in embryo transfer programs [15].

Clinical Signs

Clinical toxoplasmosis in cats is most commonly observed in immunocompromised individuals, including kittens, FIV-positive, or FeLV-positive cats. The clinical presentation is highly variable and depends on the organ systems affected. Ocular disease, including anterior uveitis, chorioretinitis, and panophthalmitis, is frequently reported [16]. Neurological signs are a hallmark of disseminated disease and are directly related to cat toxoplasmosis brain involvement. Cerebral toxoplasmosis manifests as seizures, ataxia, circling, behavioral changes, and cranial nerve deficits [17]. The pathogenesis of neurological signs involves tachyzoite invasion of astrocytes and neurons, leading to focal necrosis, perivascular cuffing, and microglial nodule formation within the cerebral cortex, brainstem, and cerebellum [17].

Respiratory signs, including dyspnea and tachypnea, result from interstitial pneumonia caused by tachyzoite proliferation within alveolar macrophages and type II pneumocytes. Gastrointestinal signs such as diarrhea, vomiting, and icterus may occur due to hepatic necrosis and lymphocytic-plasmacytic enteritis. A case series of pyogranulomatous and neutrophilic lymphadenitis in 72 cats identified toxoplasmosis as a differential diagnosis for peripheral lymphadenopathy, with nine cats exhibiting steroid-responsive lymphadenitis [18]. Subclinical infection is common, with seropositive cats showing no overt clinical signs despite harboring tissue cysts [5, 6].

Pathology

Gross pathological findings in acute feline toxoplasmosis include multifocal white to yellow necrotic foci in the liver, lungs, spleen, and lymph nodes. Pulmonary edema and consolidation are common. In the brain, gross lesions may be absent or appear as poorly demarcated areas of malacia and hemorrhage [17]. Histopathological examination reveals focal necrosis with a mixed inflammatory infiltrate composed of neutrophils, macrophages, and lymphocytes. Intracellular and extracellular tachyzoites are identifiable within affected tissues. Tissue cysts containing bradyzoites are most frequently observed in the brain, skeletal muscle, and myocardium, and are typically associated with minimal inflammation unless cyst rupture occurs [4].

The molecular pathology of feline toxoplasmosis involves dynamic changes in host microRNA expression. A study profiling microRNA expression in the feline small intestine during T. gondii infection identified 87 differentially expressed microRNAs, with predicted targets involved in immune regulation, apoptosis, and cell cycle control [19]. These microRNA alterations may contribute to the establishment of chronic infection and modulation of the host inflammatory response.

Diagnostics

Diagnostic approaches for feline toxoplasmosis encompass serological, molecular, and histopathological methods. Serological detection of anti-T. gondii IgG and IgM antibodies is the most commonly employed screening tool. Commercial ELISA kits and indirect immunofluorescence assays are widely used [20, 21]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed and field-validated for detection of T. gondii antibodies in multiple host species, including cats, providing a rapid point-of-care option with sensitivity and specificity comparable to ELISA [20]. A SAG1-based colloidal gold immunochromatographic strip has similarly been developed for swine, demonstrating the platform's cross-species applicability [21].

Molecular diagnostics offer enhanced sensitivity and specificity for active infection. Conventional PCR targeting the B1 gene or the 529 bp repetitive element is standard [7, 22]. An antisense PCR assay has been developed specifically for T. gondii detection in domestic cats, utilizing primers complementary to the sense strand of the B1 gene to improve amplification efficiency in fecal samples [22]. PCR detection of T. gondii DNA in fecal samples from stray cats in Thailand confirmed the utility of molecular methods for identifying oocyst-shedding individuals [7]. Real-time quantitative PCR allows for parasite burden quantification and is particularly useful for monitoring treatment response.

Histopathological examination of biopsy or necropsy tissues remains a definitive diagnostic method. Immunohistochemistry using polyclonal or monoclonal antibodies against T. gondii antigens can confirm the presence of tachyzoites or bradyzoites in tissue sections [4, 14]. The MIC17A antigen has been proposed as a specific marker for detecting entero-epithelial stages and chronic tissue cysts in feline intestinal biopsies [4].

The following table summarizes the diagnostic modalities for feline toxoplasmosis:

Treatment

The primary therapeutic agents for feline toxoplasmosis are clindamycin and the combination of pyrimethamine with a sulfonamide. Clindamycin is administered at 10-12 mg/kg orally every 12 hours for 4 weeks and is considered the first-line treatment for systemic and ocular toxoplasmosis. Pyrimethamine (0.25-1.0 mg/kg orally every 24 hours) combined with sulfadiazine (15-25 mg/kg orally every 12 hours) is an alternative regimen, though bone marrow suppression is a potential adverse effect requiring monitoring of hematological parameters.

Supportive care includes fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids (e.g., prednisolone at 1-2 mg/kg orally every 12-24 hours) for ocular and neurological inflammation. Anticonvulsant therapy may be necessary for cats with seizure activity secondary to cat toxoplasmosis brain involvement. Treatment should continue for at least 2 weeks beyond clinical resolution. Relapse is possible, particularly in immunocompromised patients, and long-term monitoring is recommended.

Control

Control of feline toxoplasmosis focuses on reducing environmental oocyst contamination and preventing transmission to intermediate hosts. Cats should be fed commercially processed or cooked food to eliminate ingestion of tissue cysts from raw meat [5, 6]. Indoor housing reduces exposure to infected prey and contaminated soil [5]. Litter boxes should be cleaned daily, as oocysts require 1-5 days to sporulate and become infectious. Disposal of feces in sealed bags and use of gloves during cleaning are recommended.

Environmental decontamination is challenging due to the resistance of sporulated oocysts. Oocysts are inactivated by temperatures above 55 degrees Celsius and by exposure to ammonia-based disinfectants. However, they can survive for months in soil and water. Public health education regarding the risks of raw meat consumption and outdoor access for cats is essential [23].

Vaccine development for T. gondii is an active area of research. Gene-edited live-attenuated vaccines have shown promise in preclinical studies, with targeted deletion of virulence genes resulting in protective immunity without reversion to pathogenicity [24]. Advances in antigen discovery, including mRNA vaccine platforms and One Health strategies, are being explored for both veterinary and human applications [25]. However, no commercial vaccine for feline toxoplasmosis is currently available.

The following Mermaid diagram illustrates the diagnostic and clinical decision-making workflow for feline toxoplasmosis:

flowchart TD
    A[Cat with clinical signs: neurological, ocular, respiratory, gastrointestinal], > B{Serological testing}
    B, >|IgM positive / IgG negative| C[Acute infection suspected]
    B, >|IgG positive / IgM negative| D[Chronic infection / prior exposure]
    B, >|IgG and IgM negative| E[No serological evidence of infection]
    C, > F{Confirm with PCR on blood, CSF, or tissue}
    F, >|PCR positive| G[Initiate antiprotozoal therapy]
    F, >|PCR negative| H[Consider other differential diagnoses]
    D, > I{Clinical signs present?}
    I, >|Yes| J[PCR testing to rule out active infection]
    I, >|No| K[No treatment indicated; monitor]
    J, >|PCR positive| G
    J, >|PCR negative| H
    G, > L[Clindamycin or pyrimethamine-sulfadiazine]
    L, > M[Supportive care: fluids, nutrition, anti-inflammatories]
    M, > N[Monitor clinical response and hematology]
    N, > O[Treatment for minimum 4 weeks]
    O, > P[Re-evaluate serology and PCR if signs persist]

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[3] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/

[4] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[5] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[6] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[7] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[8] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41747478/

[9] Tsakmakidis I, Moustakidis K, Alvanou MV et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. https://pubmed.ncbi.nlm.nih.gov/41970607/

[10] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[11] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[12] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[13] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[14] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[15] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[16] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[17] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[18] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a referral hospital: with a focus on nine cats with steroid-responsive lymphadenitis. J Feline Med Surg. 2026. https://pubmed.ncbi.nlm.nih.gov/41527158/

[19] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[20] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[21] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[22] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[23] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[24] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[25] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[26] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[27] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[28] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[29] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[30] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[31] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[32] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[33] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/

[34] Razali K, Issad NA, Mebkhout F et al. High seroprevalence and associated risk factors of Toxoplasma gondii infection in aborted ewes from Tebessa Province, Northeastern Algeria: A One Health perspective. Vet World. 2025. https://pubmed.ncbi.nlm.nih.gov/41472760/

[35] Spada E, Tattarletti G, Proverbio D et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41471183/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.